Schizophrenia (Heidelberg, Germany)

Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)

Asgari-Targhi A, Yao B, Brown L, Garcia S, Nagendra A, Chin K, Billah T, Penzel N, John O, Prunier N, Veale S, Kotler E, Jacobs GR, Zhan M, Coleman MJ, Bouix S, Pasternak O, Cecci G, Baker JT, Mathalon DH, Kelly SM, Corcoran CM, Reichenberg A, Winter-van Rossum I, Kubicki M, Spark J, Dwyer D, Arango C, Fusar-Poli P, Calkins M, Shah JL, Mittal V, Thompson A, McGorry PD, Kahn RS, Kane JM, Bearden CE, Woods SW, Nelson B, Shenton ME, Staglin B, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Larrauri CA, Lewandowski KE, Kapur T

Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)

Addington J, Liu L, Braun A, Auther A, Calkins ME, Cornblatt BA, Corcoran CM, Fusar-Poli P, Kerr MJ, Mourgues-Codern CV, Nunez AR, Oliver D, Strauss GP, Walsh BC, Alameda LK, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Carrion RE, Chen EYH, Choi J, Coleman MJ, Conus P, Diaz-Caneja CM, Dwyer D, Ellman LM, Faghankhani M, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui C, Jacobs GR, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Lewandowski KE, Mamah D, Marcy PJ, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Penzel N, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Thompson A, Thompson JL, Upthegrove R, Verma S, Wang J, Wastler HM, Wickham A, Rossum IW, Wolf DH, Bouix S, Pasternak O, Kahn RS, Bearden CE, Kane JM, McGorry PD, Buccilli K, Nelson B, Shenton ME, Woods SW, Accelerating Medicines Partnership® -Schizophrenia, Yung AR

Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)

Billah T, Cho KIK, Borders O, Chung Y, Ennis M, Jacobs GR, Liebenthal E, Mathalon DH, Mohandass D, Nicholas SC, Pasternak O, Penzel N, Eichi HR, Wolff P, Anticevic A, Laulette K, Nunez AR, Tamayo Z, Buccilli K, Colton BL, Dwyer DB, Hendricks L, Yuen HP, Spark J, Tod S, Carrington H, Chen JT, Coleman MJ, Corcoran CM, Haidar A, John O, Kelly S, Marcy PJ, Matneja P, McGowan A, Ray SE, Veale S, Winter-Van Rossum I, Addington J, Allott KA, Calkins ME, Clark SR, Gur RC, Harms MP, Perkins DO, Ruparel K, Stone WS, Torous J, Yung AR, Zoupou E, Fusar-Poli P, Mittal VA, Shah JL, Wolf DH, Cecchi G, Kapur T, Kubicki M, Lewandowski KE, Bearden CE, McGorry PD, Kahn RS, Kane JM, Nelson B, Woods SW, Shenton ME, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Baker JT, Bouix S

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)

Penzel N, Polosecki P, Addington J, Arango C, Asgari-Targhi A, Billah T, Bouix S, Calkins ME, Campbell DE, Cannon TD, Castro E, Cho KIK, Coleman MJ, Corcoran CM, Dwyer D, Frangou S, Fusar-Poli P, Glynn RJ, Haidar A, Harms MP, Jacobs GR, Kambeitz J, Kapur T, Kelly SM, Koutsouleris N, Abhinandan KR, Kucukemiroglu S, Kwon JS, Lewandowski KE, Li QS, Mantua V, Mathalon DH, Mittal VA, Nicholas S, Pandina GJ, Perkins DO, Potter A, Reichenberg A, Reinen J, Sand MS, Seitz-Holland J, Shah JL, Srinivasan V, Srivastava A, Stone WS, Torous J, Vangel MG, Wang J, Wolff P, Yao B, Anticevic A, Wolf DH, Zhu H, Bearden CE, McGorry PD, Nelson B, Kane JM, Woods SW, Kahn RS, Shenton ME, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Cecchi G, Pasternak O

The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program.

Schizophrenia (Heidelberg, Germany)

Harms MP, Cho KK, Anticevic A, Bolo NR, Bouix S, Campbell D, Cannon TD, Cecchi G, Goncalves M, Haidar A, Hughes DE, Izyurov I, John O, Kapur T, Kim N, Kotler E, Kubicki M, Kuperman JM, Laulette K, Lindberg U, Markiewicz C, Ning L, Poldrack RA, Rathi Y, Romo PA, Tamayo Z, Wannan C, Wickham A, Yassin W, Zhou JH, Addington J, Alameda L, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Diaz-Caneja CM, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan MS, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perez J, Perkins DO, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Stone WS, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Kahn RS, Kane JM, McGorry PD, Nelson B, Woods SW, Shenton ME, Wood SJ, Bearden CE, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Pasternak O

Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample.

Schizophrenia (Heidelberg, Germany)

Allott K, Yassin W, Alameda L, Billah T, Borders O, Buccilli K, Carrión RE, Castillo-Passi RI, Cho KIK, Chin K, Coleman MJ, Colton BL, Corral S, Dwyer D, Gundersen KB, Gur RC, Hoftman GD, Jacobs GR, Kelly S, Lewandowski KE, Marcy PJ, Matneja P, McLaughlin D, Nunez AR, Parsa S, Penzel N, Ray S, Reinen JM, Ruparel K, Sand MS, Santorelli G, Seitz-Holland J, Spark J, Tamayo Z, Thompson A, Tod S, Wannan CMJ, Wickham A, Wood SJ, Zoupou E, Addington J, Anticevic A, Arango C, Breitborde NJK, Broome MR, Cadenhead KS, Calkins ME, Chen EYH, Choi J, Conus P, Corcoran CM, Cornblatt BA, Ellman LM, Fusar-Poli P, Gaspar PA, Gerber C, Glenthøj LB, Horton LE, Hui CLM, Kambeitz J, Kambeitz-Ilankovic L, Keshavan M, Kim SW, Koutsouleris N, Kwon JS, Langbein K, Mamah D, Diaz-Caneja CM, Mathalon DH, Mittal VA, Nordentoft M, Pearlson GD, Perkins DO, Perez J, Powers AR, Rogers J, Sabb FW, Schiffman J, Shah JL, Silverstein SM, Smesny S, Strauss GP, Thompson JL, Upthegrove R, Verma SK, Wang J, Wolf DH, Pasternak O, Bouix S, McGorry PD, Kane JM, Kahn RS, Bearden CE, Shenton ME, Woods SW, Nelson B, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Stone WS